Patent · US Active

Multi-targeted single entity conjugates

US11053495B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

Alnylam Pharmaceuticals, Inc. · US

Inventors

Vasant Jadhav · Cambridge, US
Martin Maier · Cambridge, US
Ivan Zlatev · Cambridge, US
Akin Akinc · Cambridge, US
Kallanthottathil G. Rajeev · Wayland, US
Jayaprakash K. Nair · Cambridge, US
Pachamuthu Kandasamy · Cambridge, US
Muthiah Manoharan · Carlsbad, US

Key dates

Filing date	Jul 15, 2016
Grant date	Jul 6, 2021
Priority date	—
Expiry date	Jul 15, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates, in general to, compounds, compositions and methods useful for modulating gene expression of multiple target nucleic acids by a single chemical entity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.